• Opinion
• [Reporter’s View] Who’s to blame the new drug reimb delays
• by Eo, Yun-Ho Nov 15, 2024 05:49am

• Company
• Hanmi's new bio drug 'Rolvedon' sales 88%↑ in the US mkt
• by Son, Hyung Min Nov 15, 2024 05:49am

• Opinion
• [Reporter's View] The reality of drug shortage reports
• by Lee, Hye-Kyung Nov 14, 2024 05:52am

• Company
• Lee Hyun-ju named as the representative of ZP Therapeutics
• by Eo, Yun-Ho Nov 14, 2024 05:52am

• Company
• Celltrion anticipates Trump admin will bring positive shift
• by Whang, byung-woo Nov 14, 2024 05:51am

• Company
• ‘Access to bispecific antibody Columvi should be improved’
• by Son, Hyung Min Nov 14, 2024 05:51am

• InterView
• 'Early detection of RA can help prevent severe symptoms'
• by Whang, byung-woo Nov 14, 2024 05:51am

• Company
• Global CDMOs compete to expand ADC capacities
• by Kim, Jin-Gu Nov 14, 2024 05:51am

• Product
• MOHW cautions non-face-to-face Wegovy prescriptions
• by Kang Hye-Kyung Nov 13, 2024 05:55am

• Opinion
• [Reporter's View] voluntary resignation with compensation
• by Lee, Seok-Jun Nov 13, 2024 05:54am